Upfront Maintenance Olaparib in Advanced Ovarian Cancer BRCAwt Patients With Known Homologous Recombination Deficiency

NCT06120972 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Sponsor terminated due to Olaparib losing patent

Conditions

Interventions

Sponsor

Alexander B Olawaiye, MD

Collaborators